Development of an Alternative Analytical Method without Related Substance Reference Standards for Fenofibrate in Korean Pharmacopoeia
![]() |
Kim, Jung Hyun
(Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation, Drug Research Division)
Kim, Min Young (Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation, Drug Research Division) Kwon, Eun Kyung (Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation, Drug Research Division) Lee, Kwang Moon (Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation, Drug Research Division) Choi, Don Woong (Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation, Drug Research Division) |
1 | 대한민국약전 제11개정 (2014). |
2 | Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E. and Fruchart, J.-C. : Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088 (1998). DOI |
3 | Abourbih, S., Filion, K. B., Joseph, L., Schiffrin, E. L., Rinfret, S., Poirier, P., Pilote, L., Genest, J. and Eisenberg, M. J. : Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am. J. Med. 122, 962.e1 (2009). DOI |
4 | Shah, A., Rader, D. J. and Millar, J. S. : The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans. Atheroscler. 210, 35 (2010). DOI |
![]() |